SEC Filings - Ultragenyx Pharmaceutical Inc.

SEC Filings

Filing date	Description	Form	View
Mar 14, 2023	Report of unscheduled material events or corporate event	8-K	View HTML 0000950170-23-007720.pdf 0000950170-23-007720.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016041.pdf 0001209191-23-016041.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016042.pdf 0001209191-23-016042.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016039.pdf 0001209191-23-016039.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016045.pdf 0001209191-23-016045.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016046.pdf 0001209191-23-016046.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016053.pdf 0001209191-23-016053.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016047.pdf 0001209191-23-016047.xls
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-016043.pdf 0001209191-23-016043.xls
Mar 02, 2023	Statement of changes in beneficial ownership of securities	4	View HTML 0001209191-23-014502.pdf 0001209191-23-014502.xls

INVESTORS & MEDIA

SHAREHOLDER TOOLS